CRISPR-based genome editing has considerable therapeutic potential in a wide range of diseases 1,2,3,4,5. A key challenge is achieving efficient, clinically suitable delivery of genome editing ...
Short read, high-throughput, next-generation sequencing (NGS) technology has transformed our understanding of microbiology and is poised to become an integral tool in epidemiology 1. Although the ...